- Home
- /
- Treatment
- /
- Page 104
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Lestaurtinib | Acute myeloid leukemia | Teva Branded Pharmaceutical Products R&D;, Inc.;41 Moores Road, P. O. Box 4011;Frazer, Pennsylvania, 19355 | March 24, 2006 | |
N-[4-(4-amino-2-ethyl-lH-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide | Cutaneous T-cell lymphoma | Pfizer, Inc.;50 Pequot Avenue, 6025-A3106;New London, Connecticut, 06320 | March 24, 2006 | |
Ethanol gel | Congenital lymphatic malformations | Orfagen;CRDPF - LANGLADE, 31035 Toulouse Cedex; | March 13, 2006 | |
Human umbilical tissue-derived cells | Retinitis pigmentosa | Janssen Research and Development, LLC;1400 McKean Road, P. O. Box 776;Spring House, Pennsylvania, 19477 | March 13, 2006 | |
Tissue repair cells obtained from autologous bone marrow expanded ex vivo with a cell production system | Osteonecrosis | Aastrom Biosciences, Inc.;Domino's Farms, Lobby K, 24 Frank Lloyd Wright Drive;Ann Arbor, Michigan, 48105 | March 13, 2006 | |
Clotrimazole | Huntington disease | EnVivo Pharmaceuticals, Inc.;480 Arsenal Street;Watertown, Massachusetts, 02472 | March 13, 2006 | |
Thymalfasin | Metastatic Melanoma | SciClone Pharmaceuticals, Inc.;950 Tower Lane, Suite 900;Foster City, California, 94404 | March 13, 2006 | |
Amikacin | Bronchopulmonary Pseudomonas aeruginosa infections in cystic fibrosis patients | Insmed, Inc.;Princeton Corporate Plaza, 9 Deer Park Drive, Suite C;Monmouth Junction, NJ, 08852-1923 | March 9, 2006 | |
Liposomal amikacin | Cystic fibrosis | Insmed, Inc.;Princeton Corporate Plaza, 9 Deer Park Drive, Suite C;Monmouth Junction, New Jersey, 08852 | March 9, 2006 | |
Recombinant fully human monoclonal antibody to anthrax protective antigen | Anthrax | PharmAthene, Inc.;One Park Place, Suite 450;Annapolis, Maryland, 21401 | February 16, 2006 | |
Clazosentan | Cerebral vasospasm following subarachnoid hemorrhage | Idorsia Pharmaceuticals US Inc.;1820 Chapel Avenue West, Suite 150;Cherry Hill, New Jersey, 08002 | February 16, 2006 | |
Nikkomycin Z | Coccidioidomycosis | Valley Fever Center for Excellence (1-111 INF);University of Arizona;Tucson, Arizona, 85723 | February 14, 2006 | |
Bevacizumab | Ovarian cancer | Genentech, Inc;1 DNA Way, M/S# 355E;South San Francisco, California, 94080 | February 9, 2006 | |
Solasonine and solamargine | Metastatic Melanoma | Solbec Pharmaceuticals Limited;P. O. Box 2142, Osbourne Park, Western Australia 6017; | February 6, 2006 | |
6,8-bis-benzylsulfanyl-octanoic acid | Pancreatic Cancer | Cornerstone Pharmaceuticals, Inc.;25 Health Science Drive;Stony Brook, New York, 11790 | February 6, 2006 | |
Blinatumomab | Non-Hodgkin lymphoma Non-Hodgkin Lymphoma | Amgen, Inc.;One Amgen Center Drive;Thousand Oaks, California | February 6, 2006 | |
N-acetyl-glucosamine thiazoline | Adult Tay-Sachs disease | ExSAR Corporation;11 Deer Park Drive;Monmouth Junction, New Jersey, 08852 | February 6, 2006 | |
Recombinant human alpha-mannosidase | Alpha-mannosidosis | Chiesi USA, Inc.;1255 Crescent Green, Suite 250;Cary, North Carolina, 27518 | February 2, 2006 | |
Aripiprazole | Tourette syndrome | Otsuka Pharmaceutical Development;and Commercialization, 1st Floor;Princeton, New Jersey, 08540 | January 25, 2006 | |
Recombinant anti-CD-40 monoclonal antibody | Multiple myeloma | Novartis Pharmaceutical Corporation;Oncology Business Unit, One Health Plaza, Bldg 104;East Hanover, New Jersey, 07936 | January 25, 2006 | |
Recombinant human microplasmin | Peripheral arterial occlusion | ThromboGenics Ltd;Unit 14, Bridgecourt Office Park;Dublin | January 23, 2006 | |
Iobenguane I 131 | Neuroendocrine tumors | Progenics Pharmaceuticals, Inc.;One World Trade Center., 47th Floor, Suite J;New York, New York, 10007 | January 18, 2006 | |
L-aminocarnityl-succinyl-leucyl-argininal-diethylacetal | Duchenne muscular dystrophy | CepTor Corporation;200 International Circle;Hunt Valley, Maryland, 21030 | January 18, 2006 | |
Fusion protein consisting of human immunoglobim G1 constant region Fc region fused to the human receptor binding domain of ectodysplasin-A1 | X-linked Hypohidrotic Ectodermal Dysplasia | Edimer Pharmaceuticals, Inc.;1 Broadway, 8th Floor;Cambridge, Massachusetts, 02142 | January 11, 2006 | |
Lentiviral vector encoded with a human beta-globin gene plasmid | Beta-thalassemia | Memorial Sloan-Kettering Cancer Center;1275 York Avenue, Box 65;New York, New York, 10065 | January 11, 2006 |